WFDC2 and non-small cell lung carcinoma: Serum HE4 ranged from 26 to 356 pmol/L (median = 50 pmol/L) in patients with benign lung disease (controls) and from 33 to 861 (median = 98 pmol/L) in patients with NSCLC (Table 2).